September 27, 2019 /
In this video I share brand new MS drug results, comparing a new B-cell killer (Ofatumamab) to Aubagio (teriflunomide). If you’d like to learn the results and better understand Multiple Sclerosis research, then start watching this video right now!
………………………………………………………………………..
Stay Informed. Register to receive
‘The MS BEACON’ e-Newsletter: Click here
…………………………………………………………………………………….
This Article is Provided by: #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
